Press releaseGlobe Newswire
MindWalk Holdings
HYFT · NASDAQ
$1.29−$0.03 (−2.27%)TodayMarket closed ·
Prev close $1.32
Latest news
- Press releaseBusiness Wire
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
- Press releaseGlobe Newswire
Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context
- Press releaseBusiness Wire
MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function
- Press releasePRNewswire
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
- Press releaseBusiness Wire
MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director
- Press releaseGlobe Newswire
Chipmakers Now Ship Protein-Folding AI as Plug-and-Play Microservices
- Press releaseBusiness Wire
MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
- News
Transcript: MindWalk Holdings Q1 2027 Earnings Conference Call
- Press releaseBusiness Wire
MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
- Press releasePRNewswire
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
- Press releaseBusiness Wire
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
- Press releaseBusiness Wire
MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Press releaseBusiness Wire
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026
- Press releaseGlobe Newswire
The Market Just Told You Which Layer Of AI Biology It Is Paying For
- Press releasePRNewswire
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
- Press releaseGlobe Newswire
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
- Press releaseGlobe Newswire
AI Found an Influenza Target That Survives Viral Mutation
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releasePRNewswire
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
- Press releaseBusiness Wire
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI
- Press releasePRNewswire
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseBusiness Wire
MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
- Press releasePRNewswire
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
- Press releaseBusiness Wire
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026
- Press releasePRNewswire
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
- Press releaseBusiness Wire
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
- NewsVishaal Sanjay
Stock Market Today: Dow Futures, S&P 500 Advance Ahead Of Key Economic Data: iRobot, Argenx, MindWalk In Focus
- News
Earnings Outlook For ImmunoPrecise Antibodies
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.